Department of Human and Medical Genetics, Faculty of Medicine, Institute of Biomedical Sciences, Vilnius University, Vilnius, Lithuania.
The Children's Hospital, Affiliate of Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Mol Genet Genomic Med. 2019 Sep;7(9):e878. doi: 10.1002/mgg3.878. Epub 2019 Jul 20.
Preaxial polydactyly type IV, also referred as polysyndactyly, has been described in a few syndromes. We present three generations of a family with preaxial polydactyly type IV and other clinical features of Greig cephalopolysyndactyly syndrome (GCPS).
Sequencing analysis of the GLI3 coding region identified a novel donor splice site variant NC_000007.14(NM_000168.6):c.473+3A>T in the proband and the same pathogenic variant was subsequently identified in other affected family members. Functional analysis based on Sanger sequencing of the proband's complementary DNA (cDNA) sample revealed that the splice site variant c.473+3A>T disrupts the original donor splice site, thus leading to exon 4 skipping. Based on further in silico analysis, this pathogenic splice site variant consequently results in a truncated protein NP_000159.3:p.(His123Argfs*57), which lacks almost all functionally important domains. Therefore, functional cDNA analysis confirmed that the haploinsufficiency of the GLI3 is the cause of GCPS in the affected family members.
Despite the evidence provided, pathogenic variants in the GLI3 do not always definitely correlate with syndromic or nonsyndromic clinical phenotypes associated with this gene. For this reason, further transcriptomic and proteomic evaluation could be suggested.
轴前多指畸形 IV 型,也称为并指畸形,已在少数综合征中描述过。我们介绍了一个三代同堂的家庭,他们患有轴前多指畸形 IV 型和 Greig 头面多肢体综合征(GCPS)的其他临床特征。
对 GLI3 编码区的测序分析确定了一个新的供体位点剪接变异 NC_000007.14(NM_000168.6):c.473+3A>T 在先证者中,并在其他受影响的家庭成员中鉴定出相同的致病性变异。基于先证者 cDNA 样本的 Sanger 测序的功能分析显示,剪接变异 c.473+3A>T 破坏了原始的供体位点,从而导致外显子 4 跳跃。基于进一步的计算机分析,该致病性剪接变异导致截短蛋白 NP_000159.3:p.(His123Argfs*57),该蛋白几乎缺乏所有功能上重要的结构域。因此,功能 cDNA 分析证实了 GLI3 的杂合不足是受影响家庭成员中 GCPS 的原因。
尽管提供了证据,但 GLI3 的致病变异并不总是与该基因相关的综合征或非综合征临床表型明确相关。因此,可以建议进一步进行转录组和蛋白质组评估。